- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 2 residues within 4Å:- Chain A: Q.22, N.55
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: N.99, E.121
Ligand excluded by PLIPNAG.7: 5 residues within 4Å:- Chain A: N.109, S.110, T.111, N.112, I.154
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain A: F.147, N.148
- Chain B: A.329
Ligand excluded by PLIPNAG.9: 2 residues within 4Å:- Chain A: N.259
- Chain B: R.534
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain A: N.308, K.556
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain A: N.347
- Chain B: Y.432, L.433
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain A: N.592, Q.620
- Chain C: Q.808
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain A: N.681
Ligand excluded by PLIPNAG.14: 1 residues within 4Å:- Chain A: N.689
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain A: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: N.1046
- Chain C: Q.867
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain B: N.55
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain B: R.1045, N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: N.99, E.121
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain B: N.109, S.110, T.111, V.114
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain B: N.148
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: E.258, N.259
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: N.308, K.556
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: N.347
- Chain C: Y.432, Y.465
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: M.806
- Chain B: N.592, T.594
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.681, G.1103
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.689, Q.894
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: Y.768, N.773, Q.776
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: E.1044, N.1046
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: Q.22, H.23, N.55
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: N.99, E.121
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain C: N.109, S.110, T.111, N.112, I.154
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: A.329
- Chain C: N.148
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: N.308, K.556
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain A: Y.432, Y.465
- Chain C: N.347
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: Q.808
- Chain C: N.592, Q.620
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.681
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: N.689, Q.894
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain C: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: E.1044, N.1046
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.1106
Ligand excluded by PLIP- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
BLA.17: 10 residues within 4Å:- Chain A: N.86, V.88, R.89, G.90, W.91, N.108, F.158, R.173, F.175, K.188
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.91, A:F.158
- Hydrogen bonds: A:K.188
- pi-Cation interactions: A:R.173
BLA.34: 8 residues within 4Å:- Chain B: V.88, R.89, G.90, W.91, N.108, R.173, K.188, Y.190
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:W.91
- Hydrogen bonds: B:N.108
- pi-Cation interactions: B:R.173
BLA.48: 12 residues within 4Å:- Chain C: N.86, V.88, R.89, G.90, W.91, N.108, V.113, R.173, F.175, K.188, I.209, F.210
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:W.91, C:F.175, C:I.209, C:I.209, C:F.210
- Hydrogen bonds: C:N.86, C:N.108
- Salt bridges: C:K.207
- pi-Cation interactions: C:R.173, C:K.188
- 3 x EIC: LINOLEIC ACID(Non-covalent)
EIC.18: 14 residues within 4Å:- Chain A: R.385, T.392, G.393
- Chain C: C.313, P.314, V.318, I.335, A.340, Y.342, F.351, F.354, F.369, L.489, F.491
15 PLIP interactions:14 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:P.314, C:V.318, C:I.335, C:A.340, C:Y.342, C:Y.342, C:F.351, C:F.354, C:F.369, C:F.369, C:L.489, C:L.489, C:F.491, C:F.491
- Salt bridges: A:R.385
EIC.19: 14 residues within 4Å:- Chain A: C.313, F.315, I.335, A.340, Y.342, F.351, F.354, L.364, F.369, V.372, L.489
- Chain B: R.385, T.392, G.393
14 PLIP interactions:12 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.315, A:I.335, A:A.340, A:Y.342, A:Y.342, A:Y.342, A:F.351, A:F.351, A:L.364, A:F.369, A:V.372, A:L.489
- Hydrogen bonds: B:Q.386
- Salt bridges: B:R.385
EIC.20: 11 residues within 4Å:- Chain B: C.313, P.314, V.318, I.335, A.340, Y.342, Y.346, F.351, F.354, F.369, V.372
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:V.318, B:I.335, B:A.340, B:Y.342, B:Y.342, B:F.351, B:F.354, B:F.354, B:F.369, B:V.372
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes. Life Sci Alliance (2023)
- Release Date
- 2022-11-09
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
- 3 x EIC: LINOLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes. Life Sci Alliance (2023)
- Release Date
- 2022-11-09
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C